Laura B Portalupi1,2, Carmen L Lewis1,2,3, Carl D Miller2,4, Kerry L Whiteman-Jones2, Kay A Sather2, Donald E Nease1,5,6, Daniel D Matlock1,2,7. 1. Adult and Child Consortium for Health Outcomes Research and Delivery Science, School of Medicine, University of Colorado, Aurora, CO, USA. 2. Patient and Family Research Advisory Panel, University of Colorado, Aurora, CO, USA. 3. Division of General Internal Medicine, School of Medicine, University of Colorado, Aurora, CO, USA. 4. Patient and Family Centered Care, University of Colorado Hospital, Aurora, CO, USA. 5. Colorado Clinical and Translational Sciences Institute, Aurora, CO, USA. 6. Department of Family Medicine, University of Colorado, Aurora, CO, USA. 7. Division of Geriatrics, School of Medicine, University of Colorado, Aurora, CO, USA.
Abstract
Background: People who have experienced illness due to significant disease, multimorbidity and/or advanced age are high utilizers of the health care system. Yet this population has had little formal opportunity to participate in guiding the health care research agenda, and few mechanisms exist for researchers to engage this population in an efficient way. Objective: We describe the process of developing a standing patient and family advisory panel to incorporate this population's voice into research in the USA. Methods: The panel was created at the University of Colorado. Preliminary panel development consisted of a needs assessment, information gathering and participant recruitment. We collected feedback from researchers who consulted with the panel and from panel members in order to better understand the experience from the patient and family member perspective. Results: The patient and family research advisory panel consists of eight advisors who have experience with significant disease, multimorbidity and/or advanced age, two physicians and a program manager. The panel meets every other month for 2 hours with the main purpose of advising diverse researchers on health care studies. Conclusion: People with significant disease, multimorbidity and/or advanced age represent a growing demographic in the USA, and their engagement in research is essential as the model of health care delivery moves from volume to value.
Background: People who have experienced illness due to significant disease, multimorbidity and/or advanced age are high utilizers of the health care system. Yet this population has had little formal opportunity to participate in guiding the health care research agenda, and few mechanisms exist for researchers to engage this population in an efficient way. Objective: We describe the process of developing a standing patient and family advisory panel to incorporate this population's voice into research in the USA. Methods: The panel was created at the University of Colorado. Preliminary panel development consisted of a needs assessment, information gathering and participant recruitment. We collected feedback from researchers who consulted with the panel and from panel members in order to better understand the experience from the patient and family member perspective. Results: The patient and family research advisory panel consists of eight advisors who have experience with significant disease, multimorbidity and/or advanced age, two physicians and a program manager. The panel meets every other month for 2 hours with the main purpose of advising diverse researchers on health care studies. Conclusion:People with significant disease, multimorbidity and/or advanced age represent a growing demographic in the USA, and their engagement in research is essential as the model of health care delivery moves from volume to value.
Authors: Frederick A Masoudi; Edward P Havranek; Pam Wolfe; Cary P Gross; Saif S Rathore; John F Steiner; Diana L Ordin; Harlan M Krumholz Journal: Am Heart J Date: 2003-08 Impact factor: 4.749
Authors: Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie Journal: Lancet Date: 2012-05-10 Impact factor: 79.321
Authors: Kathryn A Nearing; Hope M Adams; James Alsphaugh; Serena E Douglas; Thomas R Feller; Robert Fleak; Vernon Moore; Susan Martin-Sanders; Thomas M Schultz; Karleen Stratton; J Pat Sullivan; Lance Van Sickle; J David Yates; Terry A Yates; Daniel D Matlock Journal: J Gen Intern Med Date: 2022-03-29 Impact factor: 6.473